Expression Analysis of the COPB 2 and Bcl-2 in Early Stages of Endometrial Carcinoma

Plain-language summary

This study analyzes the expression levels of the COPB2 and Bcl-2 proteins in the early stages of endometrial carcinoma. It included patients with a pathologically confirmed diagnosis of endometrial carcinoma, along with people with normal tissue and simple hyperplasia as a control group. It was conducted as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Clinical Center Kragujevac

Intervention

1.hysterectomy with bilateral oophorectomy and pelvic lymphonodectomy. 2 explorative curettage

Start date

4/17/2019

Estimated completion

10/1/2022

Related genes

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* signed informed consent of the patient
* pathohistological confirmation of endometrial carcinoma for the experimental group
* normal endometrial tissue and hyperplasia simplex endometrii for the control group.

Exclusion Criteria:

* malignant disease in the patient whose treatment is still ongoing
* pathohistological determination of atypical hyperplasia of the endometrial tissue